Swedbank’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-256,700
| Closed | -$3.95M | – | 695 |
|
|
2025
Q4 | $3.95M | Hold |
256,700
| – | – | ﹤0.01% | 588 |
|
|
2025
Q3 | $2.55M | Hold |
256,700
| – | – | ﹤0.01% | 604 |
|
|
2025
Q2 | $2.55M | Hold |
256,700
| – | – | ﹤0.01% | 590 |
|
|
2025
Q1 | $3.33M | Hold |
256,700
| – | – | ﹤0.01% | 580 |
|
|
2024
Q4 | $3.28M | Hold |
256,700
| – | – | ﹤0.01% | 584 |
|
|
2024
Q3 | $2.86M | Hold |
256,700
| – | – | ﹤0.01% | 592 |
|
|
2024
Q2 | $2.88M | Sell |
256,700
-44,700
| -15% | -$520K | ﹤0.01% | 583 |
|
|
2024
Q1 | $3.74M | Hold |
301,400
| – | – | 0.03% | 421 |
|
|
2023
Q4 | $4.21M | Hold |
301,400
| – | – | 0.01% | 537 |
|
|
2023
Q3 | $4.45M | Hold |
301,400
| – | – | 0.01% | 522 |
|
|
2023
Q2 | $3.89M | Hold |
301,400
| – | – | 0.01% | 546 |
|
|
2023
Q1 | $2.96M | Hold |
301,400
| – | – | 0.01% | 571 |
|
|
2022
Q4 | $3.21M | Hold |
301,400
| – | – | 0.01% | 547 |
|
|
2022
Q3 | $3.15M | Hold |
301,400
| – | – | 0.01% | 558 |
|
|
2022
Q2 | $3.79M | Buy |
301,400
+256,700
| +574% | +$2.73M | 0.01% | 540 |
|
|
2022
Q1 | $485K | Buy |
+44,700
| New | +$543K | ﹤0.01% | 720 |
|
Other funds holding DVAX
Swedbank's DVAX Position: Q1 2026 in Review
Swedbank sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 256,700 shares — an estimated $3.95M sold.
Swedbank first reported a position in DVAX in Q1 2022 and held it in 16 quarters. The position peaked at $4.45M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Swedbank reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Swedbank sold 256,700 Dynavax Technologies shares in Q1 2026, an estimated $3.95M.
- Swedbank first reported a position in Dynavax Technologies in Q1 2022 and held it in 16 quarters.
- Swedbank's Dynavax Technologies position peaked at $4.45M in Q3 2023.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Swedbank's 13F filing for Q1 2026, filed 29 Apr 2026.